Lv2
166 积分 2025-01-14 加入
Modulating the Binding Kinetics of Bruton’s Tyrosine Kinase Inhibitors through Transition-State Effects
2天前
已完结
Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms
15天前
已完结
Multigene expression in stable CHO cell pools generated with the piggyBac transposon system
27天前
已完结
Uncoupling of PARP1 trapping and inhibition using selective PARP1 degradation
1个月前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
1个月前
已完结
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
1个月前
已完结
Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK
1个月前
已完结
Therapeutic landscape and future direction of metastatic colorectal cancer
1个月前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
1个月前
已完结
Context-dependent synthetic lethality — an emerging precision therapeutic approach
1个月前
已完结
皖公网安备34019202002308
